Safety of Intravenous Thrombolytics in Stroke on Awakening

Trial Profile

Safety of Intravenous Thrombolytics in Stroke on Awakening

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Alteplase (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions
  • Acronyms SAIL-ON
  • Most Recent Events

    • 05 Mar 2017 Status changed from recruiting to completed.
    • 16 Jan 2014 As per ClinicalTrials.gov record planned end date changed from 1 Jul 2014 to 1 Dec 2014.
    • 28 Jan 2013 Planned End Date changed from 1 Sep 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top